Skip to main content

News

Press Release
09/02/2014
The first expert consensus on ventricular arrhythmias is published. The novel document compiles current evidence on the diagnosis and management of ventricular arrhythmias and was agreed by international experts from three continents. The...
The first expert consensus on ventricular arrhythmias is published. The novel document compiles current evidence on the diagnosis and management of ventricular arrhythmias and was agreed by international experts from three continents. The...
The first expert consensus on...
09/02/2014
EP Lab Digest
Press Release
09/02/2014
Daiichi Sankyo and the Heart Rhythm Society announced results from a global survey, which polled cardiologists from around the world and revealed that a majority (58%) of cardiologists agree that there is no such thing as a "typical"...
Daiichi Sankyo and the Heart Rhythm Society announced results from a global survey, which polled cardiologists from around the world and revealed that a majority (58%) of cardiologists agree that there is no such thing as a "typical"...
Daiichi Sankyo and the Heart...
09/02/2014
EP Lab Digest
Press Release
09/02/2014
At the European Society of Cardiology congress and published simultaneously in the New England Journal of Medicine, Novartis revealed that its investigational heart failure medicine, LCZ696, was superior to ACE-inhibitor enalapril on key...
At the European Society of Cardiology congress and published simultaneously in the New England Journal of Medicine, Novartis revealed that its investigational heart failure medicine, LCZ696, was superior to ACE-inhibitor enalapril on key...
At the European Society of...
09/02/2014
EP Lab Digest
Press Release
09/02/2014
St. Jude Medical Quartet quadripolar lead performed better than bipolar leads of any kind St. Jude Medical, Inc., a global medical device company, announced results from a large-scale, clinical study concluding that the St. Jude Medical...
St. Jude Medical Quartet quadripolar lead performed better than bipolar leads of any kind St. Jude Medical, Inc., a global medical device company, announced results from a large-scale, clinical study concluding that the St. Jude Medical...
St. Jude Medical Quartet...
09/02/2014
EP Lab Digest
Press Release
09/02/2014
Milestone Coincides with Patent Approval for Company’s Nerve Stimulation Electrode, Solidifying its Leading Position in Neurostimulation Therapy BioControl Medical announced that it has reached an important clinical trial milestone,...
Milestone Coincides with Patent Approval for Company’s Nerve Stimulation Electrode, Solidifying its Leading Position in Neurostimulation Therapy BioControl Medical announced that it has reached an important clinical trial milestone,...
Milestone Coincides with Patent...
09/02/2014
EP Lab Digest
Press Release
09/02/2014
Results from the BIOTRONIK-sponsored European Health Economic Trial on Home Monitoring in ICD Therapy (EuroEco) were presented by lead investigator Dr. Hein Heidbuchel at a Hot Line session at the European Society of Cardiology’s annual...
Results from the BIOTRONIK-sponsored European Health Economic Trial on Home Monitoring in ICD Therapy (EuroEco) were presented by lead investigator Dr. Hein Heidbuchel at a Hot Line session at the European Society of Cardiology’s annual...
Results from the...
09/02/2014
EP Lab Digest
Press Release
08/27/2014
ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced that it will display the LifeVest Wearable Defibrillator along with sudden cardiac death (SCD) education and screening tools, the...
ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced that it will display the LifeVest Wearable Defibrillator along with sudden cardiac death (SCD) education and screening tools, the...
ZOLL Medical Corporation, a...
08/27/2014
EP Lab Digest
Press Release
08/27/2014
Post-Market Clinical Trial Will Assess Superiority of the AdaptivCRT® Feature Compared to Standard CRT Medtronic, Inc. announced the first implants in a clinical trial that will compare patient and healthcare system outcomes - including...
Post-Market Clinical Trial Will Assess Superiority of the AdaptivCRT® Feature Compared to Standard CRT Medtronic, Inc. announced the first implants in a clinical trial that will compare patient and healthcare system outcomes - including...
Post-Market Clinical Trial Will...
08/27/2014
EP Lab Digest
Press Release
08/25/2014
Medtronic, Inc. announced the U.S. Food and Drug Administration (FDA) approval of its newest cardiac resynchronization therapy-pacemaker, Viva® CRT-P, for indicated patients with heart failure or atrioventricular (AV) block. The Viva CRT-P...
Medtronic, Inc. announced the U.S. Food and Drug Administration (FDA) approval of its newest cardiac resynchronization therapy-pacemaker, Viva® CRT-P, for indicated patients with heart failure or atrioventricular (AV) block. The Viva CRT-P...
Medtronic, Inc. announced the...
08/25/2014
EP Lab Digest
Press Release
08/21/2014
Patients are able to instantly identify atrial fibrillation in real-time ECG recordings AliveCor, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted the company clearance for its algorithm to detect atrial...
Patients are able to instantly identify atrial fibrillation in real-time ECG recordings AliveCor, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted the company clearance for its algorithm to detect atrial...
Patients are able to instantly...
08/21/2014
EP Lab Digest